Speedy delivery to hospitals and clinics is the goal
Tailored to the needs of hospitals who are seeking medical devices quickly, the FSL network of UPS has been upgraded to provide compliant shipping and delivery. The 36 FSL locations in the US, says UPS, can deliver needed products to 80% of hospital beds in the country within four hours.
The FSL concept is not unique to life sciences; in fact, UPS has over 950 such locations globally, and routinely serves high tech, aerospace, industrial and other clients from them since 1995. The different here, apparently, is that UPS has ensured that products are stored in a regulatory-compliant manner, including temperature control for refrigerated products (a significant fraction of the “medical device” universe includes things like kits containing drugs, as well as products like human tissues).
The medical-device community is still in a longterm process of upgrading its inventory and supply-chain practices; a significant fraction of medical devices routinely reside in the trunks of sales reps’ cars (thus, the term “trunk inventory”). FSLs represent not just an upgrade of quality standards for device manufacturers, but also a way to run their supply chains closer to marketplace demands.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.